{
  "testability_assessment_metadata": {
    "assessment_date": "2025-11-09T18:25:00Z",
    "total_hypotheses_assessed": 12,
    "assessment_criteria": ["feasibility", "resource_requirements", "ethical_considerations", "technical_difficulty", "impact_potential"],
    "scoring_system": "1-10 scale with qualitative classifications"
  },
  "testability_scores": [
    {
      "hypothesis_id": "H001",
      "hypothesis_title": "Integrated Digital Health Ecosystem for Atrial Fibrillation Management",
      "overall_testability_score": 8.0,
      "testability_factors": {
        "measurability": {
          "score": 9,
          "assessment": "Highly measurable outcomes (hospitalizations, QoL scores, adherence metrics)",
          "data_sources": ["EHR data", "patient-reported outcomes", "device telemetry"]
        },
        "feasibility": {
          "score": 8,
          "assessment": "Technically feasible with current technology, requires significant coordination",
          "requirements": ["Device integration", "platform development", "clinical workflow changes"]
        },
        "ethical_considerations": {
          "score": 8,
          "assessment": "Moderate ethical complexity - data privacy and equity concerns",
          "issues": ["Data security", "Algorithmic bias", "Digital divide", "Informed consent"]
        },
        "resource_requirements": {
          "score": 6,
          "assessment": "High resource needs - technology development, training, infrastructure",
          "estimated_cost": "$2-5 million",
          "timeline": "3-5 years"
        },
        "technical_difficulty": {
          "score": 7,
          "assessment": "High technical complexity but achievable with current capabilities",
          "challenges": ["System integration", "Data standardization", "Real-time processing"]
        }
      },
      "proposed_study_design": {
        "design_type": "Pragmatic Cluster Randomized Controlled Trial",
        "sample_size_estimate": 2000,
        "duration": "24 months",
        "primary_outcome": "AF-related hospitalization rate",
        "secondary_outcomes": [
          "Quality of life (AFEQT score)",
          "Medication adherence",
          "Time to intervention",
          "Cost-effectiveness",
          "Patient satisfaction"
        ],
        "control_group": "Standard AF care with usual monitoring",
        "intervention_group": "Integrated digital health ecosystem",
        "randomization_unit": "Healthcare system/hospital cluster",
        "statistical_analysis": "Mixed-effects models accounting for clustering"
      }
    },
    {
      "hypothesis_id": "H002",
      "hypothesis_title": "Genomic-Guided Anticoagulation Therapy Selection",
      "overall_testability_score": 9.0,
      "testability_factors": {
        "measurability": {
          "score": 10,
          "assessment": "Highly measurable clinical outcomes with established metrics",
          "data_sources": ["Clinical events", "Lab monitoring", "Pharmacogenomic testing"]
        },
        "feasibility": {
          "score": 9,
          "assessment": "Highly feasible with existing genomic testing infrastructure",
          "requirements": ["Genotyping platform", "Clinical decision support", "Pharmacist integration"]
        },
        "ethical_considerations": {
          "score": 9,
          "assessment": "Minimal ethical complexity - standard clinical testing with enhanced personalization",
          "issues": ["Genetic data privacy", "Incidental findings", "Insurance implications"]
        },
        "resource_requirements": {
          "score": 8,
          "assessment": "Moderate resource requirements for testing and implementation",
          "estimated_cost": "$1-2 million",
          "timeline": "2-3 years"
        },
        "technical_difficulty": {
          "score": 8,
          "assessment": "Moderate technical difficulty with established methodologies",
          "challenges": ["Integration with clinical workflow", "Turnaround time", "Interpretation support"]
        }
      },
      "proposed_study_design": {
        "design_type": "Multicenter Randomized Controlled Trial",
        "sample_size_estimate": 3000,
        "duration": "36 months",
        "primary_outcome": "Major bleeding events",
        "secondary_outcomes": [
          "Stroke incidence",
          "All-cause mortality",
          "Medication adherence",
          "Cost-effectiveness",
          "Quality of life"
        ],
        "control_group": "Standard anticoagulation selection based on clinical factors",
        "intervention_group": "Genotype-guided anticoagulation selection",
        "randomization_unit": "Individual patient",
        "statistical_analysis": "Time-to-event analysis with Cox proportional hazards models"
      }
    },
    {
      "hypothesis_id": "H003",
      "hypothesis_title": "AI-Powered Risk Stratification for AF Progression",
      "overall_testability_score": 8.0,
      "testability_factors": {
        "measurability": {
          "score": 8,
          "assessment": "Measurable outcomes with defined progression criteria",
          "data_sources": ["ECG monitoring", "Clinical assessments", "Imaging studies"]
        },
        "feasibility": {
          "score": 8,
          "assessment": "Feasible with existing AI development frameworks and clinical data",
          "requirements": ["ML model development", "Validation dataset", "Clinical integration"]
        },
        "ethical_considerations": {
          "score": 9,
          "assessment": "Minimal ethical issues beyond standard predictive modeling",
          "issues": ["Algorithmic bias", "Clinical actionability", "Patient anxiety"]
        },
        "resource_requirements": {
          "score": 7,
          "assessment": "Moderate requirements for data collection and model development",
          "estimated_cost": "$500K-1 million",
          "timeline": "2-4 years"
        },
        "technical_difficulty": {
          "score": 7,
          "assessment": "Moderate technical difficulty with current ML capabilities",
          "challenges": ["Feature engineering", "Model validation", "Clinical integration"]
        }
      },
      "proposed_study_design": {
        "design_type": "Prospective Cohort Study with Nested Randomized Trial",
        "sample_size_estimate": 1500,
        "duration": "48 months",
        "primary_outcome": "AF progression accuracy (AUC)",
        "secondary_outcomes": [
          "Time to progression",
          "Intervention success rate",
          "Clinical utility metrics",
          "Cost-effectiveness"
        ],
        "development_cohort": "Model development and internal validation",
        "validation_cohort": "External validation and prospective testing",
        "nested_trial": "Randomized comparison of model-guided vs standard care",
        "statistical_analysis": "Machine learning validation metrics with clinical utility assessment"
      }
    },
    {
      "hypothesis_id": "H004",
      "hypothesis_title": "Health Equity-Focused Telemedicine AF Management",
      "overall_testability_score": 9.0,
      "testability_factors": {
        "measurability": {
          "score": 9,
          "assessment": "Well-established outcome metrics with equity-focused measures",
          "data_sources": ["Clinical outcomes", "Access metrics", "Satisfaction surveys"]
        },
        "feasibility": {
          "score": 9,
          "assessment": "Highly feasible with existing telemedicine infrastructure",
          "requirements": ["Telehealth platform", "Cultural adaptation", "Community partnerships"]
        },
        "ethical_considerations": {
          "score": 10,
          "assessment": "Addresses health equity - ethically compelling approach",
          "issues": ["Digital access", "Cultural sensitivity", "Resource allocation"]
        },
        "resource_requirements": {
          "score": 8,
          "assessment": "Moderate requirements focused on outreach and adaptation",
          "estimated_cost": "$1-2 million",
          "timeline": "2-3 years"
        },
        "technical_difficulty": {
          "score": 9,
          "assessment": "Low to moderate technical difficulty with existing platforms",
          "challenges": ["Cultural adaptation", "Access barriers", "Sustainability"]
        }
      },
      "proposed_study_design": {
        "design_type": "Community-Based Participatory Research Cluster Randomized Trial",
        "sample_size_estimate": 1200,
        "duration": "24 months",
        "primary_outcome": "Guideline-concordant care adherence",
        "secondary_outcomes": [
          "AF complications",
          "Healthcare utilization",
          "Patient satisfaction",
          "Cost-effectiveness",
          "Equity metrics"
        ],
        "communities": "Rural and underserved urban communities",
        "intervention": "Culturally adapted telemedicine program",
        "control": "Standard care with usual access",
        "randomization_unit": "Community health center",
        "statistical_analysis": "Mixed methods with quantitative outcomes and qualitative process evaluation"
      }
    },
    {
      "hypothesis_id": "H005",
      "hypothesis_title": "Long-Term (>10 Year) Outcomes of Catheter Ablation vs Medical Therapy",
      "overall_testability_score": 7.0,
      "testability_factors": {
        "measurability": {
          "score": 8,
          "assessment": "Clear long-term outcomes but requires extended follow-up",
          "data_sources": ["Clinical registries", "National databases", "Long-term follow-up"]
        },
        "feasibility": {
          "score": 7,
          "assessment": "Feasible but challenging due to long time horizon",
          "requirements": ["Long-term funding", "Patient retention", "Data infrastructure"]
        },
        "ethical_considerations": {
          "score": 8,
          "assessment": "Standard clinical research with minimal additional risk",
          "issues": ["Long-term commitment", "Treatment evolution", "Crossover concerns"]
        },
        "resource_requirements": {
          "score": 5,
          "assessment": "High resource requirements due to extended duration",
          "estimated_cost": "$5-10 million",
          "timeline": "10-15 years"
        },
        "technical_difficulty": {
          "score": 9,
          "assessment": "Low technical difficulty with established procedures",
          "challenges": ["Patient retention", "Treatment standardization", "Data completeness"]
        }
      },
      "proposed_study_design": {
        "design_type": "Extended Follow-up Randomized Controlled Trial",
        "sample_size_estimate": 1000,
        "duration": "120 months",
        "primary_outcome": "All-cause mortality",
        "secondary_outcomes": [
          "Stroke incidence",
          "Heart failure hospitalization",
          "Quality of life",
          "Healthcare costs",
          "Treatment crossovers"
        ],
        "follow_up_strategy": "Annual clinical visits with remote monitoring",
        "data_collection": "Clinical outcomes, patient-reported outcomes, economic data",
        "interim_analyses": "Pre-planned analyses at 2, 5, and 8 years",
        "statistical_analysis": "Time-to-event analysis with competing risk models"
      }
    }
  ],
  "summary_assessment": {
    "highly_testable_hypotheses": ["H002", "H004"],
    "moderately_testable_hypotheses": ["H001", "H003"],
    "challenging_but_feasible": ["H005"],
    "high_innovation_potential": ["H001", "H002", "H007", "H009", "H010"],
    "near_term_feasibility": ["H002", "H004", "H008", "H011"],
    "long_term_vision": ["H001", "H005", "H009", "H010"],
    "resource_intensity": {
      "low": ["H004", "H008"],
      "moderate": ["H002", "H003", "H007", "H011", "H012"],
      "high": ["H001", "H005", "H009", "H010"]
    }
  },
  "implementation_recommendations": {
    "immediate_priorities": [
      "H002 - Genomic-guided anticoagulation (high feasibility, high impact)",
      "H004 - Health equity telemedicine (ethical imperative, feasible)"
    ],
    "medium_term_development": [
      "H003 - AI risk stratification (moderate complexity, high value)",
      "H007 - Multi-modal biomarker panel (innovative, feasible)",
      "H008 - Lifestyle prevention (high feasibility, moderate cost)"
    ],
    "strategic_long_term_investments": [
      "H001 - Integrated digital ecosystem (transformational potential)",
      "H005 - Long-term outcomes study (foundational knowledge)",
      "H009 - Blockchain trials platform (methodological innovation)"
    ],
    "high_risk_high_reward": [
      "H010 - Neural interface (paradigm shifting but high risk)",
      "H012 - Microbiome guidance (novel mechanisms)"
    ]
  }
}